Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 221 - China Biocontroversy, Plus: Diversity Matters
	Category:		Science & Medicine
	Duration:		00:31:52
	Publish Date:		2024-03-12 00:00:00
	Description:		A congressional committee meeting last week on biotech and national security provided a glimmer of hope that lawmakers could be persuaded to consider taking steps to bolster the U.S. bioeconomy, BioCentury Washington Editor Steve Usdin explains why the at times cartoonish spectacle of lawmakers pushing anti-China biotech bills highlights the need for scientists and entrepreneurs to build relationships in Washington. Plus: Editor in Chief Simone Fishburn argues that the future of diversity should not be bound up in the fate of DEI. And BioCentury's editors discuss the pivotal trial setback for Amylyx in ALS and what may be on FDA’s agenda as is schedules an advisory meeting for Lilly's Alzheimer's therapy donanemab.
	Total Play:		0